ABSTRACT. An Epstein-Barr virus-transformed B-cell line derived from a patient with severe combined immunodeficiency who died of a lymphoreticular malignancy has been characterized. The line derived from bone marrow cultures and designated DV-I shows surface and cytoplasmic IgM and staining with fluorescent monoclonal antibodies against immunoglobulin heavy and light chains p, 6, and K, Dr, and several other B-cell surface antigens. DV-1 secretes IgM, and demonstrates monoclonality on analysis of immunoglobulin heavy and light chain gene rearrangement patterns. Incubation with either phytohemagglutinin or pokeweed mitogen failed to cause significant stimulation of ~roliferation of DV-1 and another EBVtransformed ~-i e l l line derived from an immunologically normal host (LA-350), whereas incubation with Staphylococcus aureus Cowan strain 1 led to significant inhibition of DV-I and LA-350. Rabbit IgG antibody specific for human immunoglobulin p-chains produced a dose dependent stimulation of both lines. The resDonses of DV-1 and LA-350 to mitogens and anti-p were ;lot a s high a s those of normal peripheral blood lymphocytes. This spontaneously derived Epstein-Barr virus-transformed B-cell line from a patient with severe combined immunodeficiency demonstrated functional characteristics similar to a B-cell line derived from an immune competent host. While these cells spontaneously incorporate 200 times more thymidine than normal resting peripheral blood lymphocytes, they retain their ability to be modulated by antiimmunoglobulin, and staphylococcal Cowan strain 1, but are unresponsive to the effects of B-cell growth factor. The polyclonal activation of immunoglobulin production and the proliferative transformation of a subpopulation of B-cells after infection with EBV has been known for some time (I). The morphological, proliferative, and functional characteristics of Bcell lines derived both spontaneously from EBV-infected hosts and by in vitro transformation of B-cells by certain strains of EBV have been reviewed by Nilsson and Klein (2) . EBV transformation with malignant polyclonal and monoclonal proliferation of B-cells has been documented in a number of reports in both primary and secondary immune deficient hosts and has recently been reviewed (3) .
We reDort initial studies characterizing a LBL derived from a 12-~r-old patient who died of an ~~~r a s s o c i a t e d lymphoproliferative malignancy after bone marrow transplantation for SCID. The phenotypic and functional characteristics of this line are described and cornparcd to another LBL derived from an immune competent patient (LA-350) and to normal peripheral blood lymphocytes.
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ROSENBLATT ET AL. cultured at 37" C in medium containing RPMI 1640 and 15% heat inactivated FCS with a bicarbonate-5% C 0 2 buffer system. Unused aliquots of cells were frozen viably and stored in liquid nitrogen. Cell line LA-350 derived by EBV transformation of peripheral blood B lymphocytes from a patient with neuroblastoma prior to any therapy was the kind gift of Dr. R. C. Seeger (UCLA Center for Health Sciences, Los Angeles, CA) and was maintained in Waymouth's media supplemented with 15% FCS and antibiotics. PBL were obtained from normal adults and purified in a mononuclear cell suspension using a Ficoll-Hypaque gradient (4) .
Cell szlrfbce antigen phenotyping. Nonsynchronous cell cultures were examined for a number of cell surface antigens defined by monoclonal antibodies obtained from commercial sources. Standard methods of indirect immunofluorescence followed by flow cytometry using a Coulter EPICS V and computerized analysis of the histograms by the IMMUNO program (Coulter Electronics, Hialeah, FL) was used to determine percentages of cells positive for each marker. A panel of monoclonal antibodies defining well accepted surface antigens commonly associated with certain functional and maturational features of T and B lymphocytes and NK was selected to characterize the DV-1 line.
We routinely utilize most of these markers in characterizing the lymphocytes of our immunodeficient patients including the patient from whom DV-l was derived (5 (1 5) demonstrated the presence of BCGF activity in such supernates. Cultures were set up with 5 x lo4 LBLs or I X lo5 normal PBL. Cells were incubated for 48 h at 37" C with varying dilutions of either intact R/H anti-p or rabbit ( F~i b ' )~ anti-p (Cappel Laboratories, Cochranville, PA). During the final 18-24 h, 2 mCi of [%I]dThd was added to each 200-p1 culture. Cells were harvested and counted by liquid scintillation spectrometry as above. Those cultures performed in the presence of BCGF contained a final concentration of 20% BCGF-containing supernate and were handled in the same manner. Cultures stimulated with SAC contained 1 x lo5 normal PBL or 1 x lo4 LBL (DV-1 or LA-350) and varying dilutions of SAC (Bethesda Research Laboratories Inc., Gaithersburg, MD.) either with or without 20% BCGF containing supernates. Cultures were pulsed as above during the last 24 h of incubation at 37" C in 5% COz atmosphere and cells were harvested and counted in a liquid scintillation counter as above.
RESULTS
Establishment of' cell line DV-I. Within the first 3-5 days of culture all bone marrow cultures contained a population of adherent fibroblast-like cells and a polymorphic population of nonadherent cells in suspension. Successful subculturing of nonadherent cells was initially dependent on the presence of this autologous adherent feeder layer. Commerical fibroblast (WI-38) monolayers were not capable of supporting growth of the nonadherent cells in suspension. After 6-8 wk of subculturing bone marrow cells with adherent feeder layers, the lymphoblastoid cells became capable of growth independent of the adherent cell layer. It is these bone marrow derived, feeder layer-independent cells which were termed DV-I and were subsequently characterized. Figure  3 . The cell line DV-I appears to be a B-cell-derived line as thcrc is no significant detection of typical T cell markers using monoclonal reagents and 97 and 9 1 % of the cells were positive for Dr and B1 markers, respectively. Furthermore, the majority of cells bear IgM heavy chains and K light chains on their surface while fewer than 20% show detectable IgG or X light chains. In addi- Percentages of these markers on the LBL lines DV-I and LA-350 are summarized in Table 1 . It is interesting that the premortem PBL of the patient displayed marked reactivity with B I, Dr, T10 and NKH-1 antibodies (5) .
Gene reurrungernent studies. Autoradiograms for both immunoglobulin hcavy chain and K light chain gene rearrangements (Fig. 4) cach showcd one germline band and one clonally rear-' ranged nongermline band. The findings of a single intense rearranged band for both heavy and light chain genes and the equal intensity of the germline and rearranged bands suggest the presence of a monoclonal population of DV-1 cells in which one allele is rearranged and the other is not. Interestingly, the patterns noted in thc autoradiogram from DV-1 did not match the patterns of any of the tumors found at postmortem examination of the patient from whom the line was derived. Two monoclonal lesions found in the lung and jejunum showed only K light chain gene rearrangement. Lesions from several other locations showed oligoclonal J,, banding patterns and evidence for rearrangement of K and X genes (5).
Proli/i?rutive stzidies. The dose-dependent proliferative response of DV-1, LA-350, and control PBL to PHA and PWM is illustrated in Table 2 . Compared to the usual proliferative responses of normal PBLs to these mitogens, only a minimal response was seen in either DV-1 and LA-350, respectively, at the highest concentration of PHA. These trends began as early as 48 h incubation and were still detectable after incubation for 96 h with the appropriate mitogens. T o determine if there was a time-dependent effect of PWM on these cells, incubations were carried out using the highest PWM concentration pg/ml produced a dose-dependent stimulation of thymidine incorporation of all three cell types (Table 3 ). This effect appeared to be specific since previous studies utilizing irrelevant proteins such as control rabbit antiserum, murine monoclonal antibodies against human Thy-1, and a human neuroblastoma associated surface antigen caused no alteration in cell proliferation (data not shown). From the data shown in Table 3 it appears that while the BCGF containing supernatant enhanced the proliferative effects of anti-p on PBL by 40 to 240% at different concentrations of anti-p; no such enhancement was seen for DV-1 or LA-350. There was not a significant difference between stimulation with the intact Ig molecule as compared with the divalent F(ab')2 fragment (data not shown). Interestingly, at the lower concentrations, stimulation was more consistent for the LBLs than for normal PBLs.
Prolifirulive e/li.cts of SAC. Preliminary studies established that maximal ['HIdThd incorporation by normal unseparated PBLs occurred at 96 h and by LBL at 72 h over a wide range of dilutions of SAC. The proliferative effects of SAC on PBL, DV-I, and LA-350 over a wide range of dilutions at 72 h are shown in Table 4 . The typical stimulatory effect of SAC is demonstrated for PBL with a 6-fold increase in ['HIdThd uptake at a 1:5000 Other studies. Immunoglobulin secretion of DV-I and LA-350 was determined by quantitation of supernatants from cultures intially seeded at a cell density of 5 x lo4 cells/ml in Costar 25-mm flasks. Samples were harvested by centrifugation at 1000 x g for 10 min at varying incubation times and supernatants were stored at -20" C until assayed. Using the ELISA methods described above no IgG was detected and the IgM content of DV-1 and LA-350 supernatants ranged from 900 to 1200 ng/ml and 200 to 400 ng/ml, respectively, depending on the culture conditions. No specific binding activity for either EBV antigens by indirect immunofluorescence (Dr. Ciro Sumaya, San Antontrol second step stained cells. Values represent the percent of the total shifts of greater than 20% were required before considering a cell positive nio, TX) or for neuroblastorna surface antigens by radioimmunoassay (16) was noted in respective supernatants.
DISCUSSION
The clinical data on the patient from whom this cell line was produced have been reported recently (5, 14) . T o summarize his immunological status, he had always shown absolute lymphopenia generally with absolute counts of approximately 400 cells/ mm3. Total T-cells by E rosettes usually ranged from 5-15% (normal 43-8 1 %) and sIg+ lymphocytes were usually elevated, ranging from 15-49% (normal 6-18%). Most of the B-cells stained for IgM and IgD but lacked IgG and IgA. Monoclonal antibody staining of surface markers showed T3, T4, T8, and T I 1 consistently below 25, 14, 10, and 23%, respectively, for at least 2 yr prior to transplantation. The B-cell markers Ial and B1 were usually elevatcd at 68 and 45%, respectively. Functionally, serum immunoglobulin levels for IgG, IgA, and IgM were consistently <lo, 20, and 50 mg/dl, respectively, with no evidence for specific antibody production to diphtheria, tetanus, or blood group antigens. In vilro proliferation studies to PWM, PHA, Con-A, and several bacterial and fungal antigens was consistently depressed, but MLC reactivity was present.
DV-I shows many of the characteristics that have been attributed to EBV-derived LBLs. This line arose spontaneously with a relatively short delay period (only 2-3 wk) and cell growth was dependent on the presence of a "feeder" layer for 60-90 days. Subsequently the line grew independently in suspension demonstrating the typical pattern of growth and "classic" lymphoblastoid morphology. The cells were pleomorphic in culture and had a baseline [%]dThd incorporation 60-100 times that of normal unstimulated PBL. The presence of predominantly IgM, with some expression of IgD by these cells and the absence of chromosomal abnormalities distinguish them from most Burkitt's lymphoma lines and other clonally transformed non-Hodgkin's lymphoma cell lines. The B-cell origin of these cells is suggested by the presence of membrane bound IgM and IgD, Dr, B4, B7, BI, and 37.1 surface markers and the absence of the common T-cell markers T3, T4, T8, and T i I. The cells were not responsive to stimulation with either PHA or the T-celldependent PWM, whereas B-cell activators SAC and antiserum to pheavy chains showed significant inhibitory and stimulatory effects, respectively. Both LA-350 and DV-I cells differed from PBL in their lack of enhancement of anti-pinduced proliferation by the BCFG-containing supernatant. Although there appeared to be some reversal of the anti-pstimulated proliferation of LA350 by BCGF, the DV-1 cells showed no such reversal in the presence of BCGF.
The host derivation of DV-I was confirmed by the 46XY karyotype and the HLA phenotype. Virtually 100% of these cells were positive for EBNA on fluorescence and the presence of EBV DNA was confirmed by hybridization studies. The finding of 5-10 EBV genome equivalients per cell and the spontaneous in vitro production of 900-1200 ng/ml of IgM are comparable with other EBV transformed LBLs which have been studied (2) .
Two features distinguish DV-1 from most other LBL. Outgrowth of DV-I showed a 2-to 3-wk "lag" period. Although somewhat subjective this is clearly different from the 30-100 days reported for most LBL from infectious mononucleosis patients and more closely resembles outgrowth of Burkitt's lym- (2, 19) . The monoclonality of DV-1 suggested by the virtual absence of X light chain and confirmed by Ig gene rearrangement (Fig. 4) was detected in the 2nd month of culture.
Early monoclonal restriction might be explained by the preexistent B-cell defect demonstrated in 1979 prior to EBV exposure (14) , the lack of normal T-cell control of isotype diversity, or the selective in vitro outgrowth of B-cells present in the marrow which were already monoclonally transformed but not detectable grossly or microscopically.
The stage of maturation of DV-I may be analyzed by the expression of various surface differentiation antigens. The typical B-cell differentiation antigens B 1, B4, and B7 as well as coexpression of IgM and IgD imply differentiation to a mature but "naive" B-cell. Moreover, the B2 marker, associated with the EBV receptor and demonstrated to show activation and cell cycle-dependent expression (20) , was demonstrated on roughly 30% of unsynchronized cells.
The correlation between EBV immortalization and immunoglobulin secretion has been demonstrated in two recent reports (21, 22) . While it is clear that only about 50% of normal B-cells capable of stimulated immunoglobulin secretion are immortalized by EBV (2 I), it is not clear what relationship the pattern of antigenic expression on DV-1 has with respect to its functional properties of spontaneous IgM secretion or the specific, although modest, modulation of proliferative activity of LA-350 and DV-I by SAC and anti-g. These findings are compatible with functional studies on malignant B-and T-cells reported by other authors (23, 24) . Such modest effects on DNA synthesis and cell proliferation triggered by activation events at the cell membrane have been associated with dramatic effects on cellular metabo-lism and constitutive synthesis of a number of glycoprotein receptors and phospholipid turnover (25) (26) (27) (28) .
It would appear from our preliminary observations that these LBLs may be subject to some of the same regulatory mechanisms as normal B-cells, and further study of this LBL model system holds significant potential for the effective production of human monoclonal antibodies by LBL, the elucidation of some mechanisms involved in viral B-cell activation, and the clarification of some intrinsic B-cell defects present in patients with humoral immunodeficiencies.
